- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT06689800
Soyons réalistes : outil de communication sur la santé familiale dans le domaine de la greffe de cellules souches pédiatriques et de la thérapie cellulaire
Soyons réalistes : un essai pilote d'un outil de communication sur la santé familiale dans le domaine de la greffe de cellules souches pédiatriques et de la thérapie cellulaire
The investigators will conduct a pilot feasibility and efficacy trial of a newly developed family health communication tool (called Let's Get REAL) in increasing youth involvement in real-time stem cell transplant and cellular therapy decisions (SCTCT). The investigators will pilot the intervention among 24 youth and their parents, stratified by youth age (stratum 1, 8-12 years of age and stratum 2, 13-17 years of age).
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Ginny L Schulz, Ph.D., RN, CPNP-PC
- Numéro de téléphone: 314-454-6018
- E-mail: schulz_g@wustl.edu
Lieux d'étude
-
-
Missouri
-
St Louis, Missouri, États-Unis, 63110
- Recrutement
- Washington University School of Medicine
-
Sous-enquêteur:
- Shalini Shenoy, M.D.
-
Contact:
- Ginny L Schulz, Ph.D., RN, CPNP-PC
- Numéro de téléphone: 314-454-6018
- E-mail: schulz_g@wustl.edu
-
Chercheur principal:
- Ginny L Schulz, Ph.D., RN, CPNP-PC
-
Sous-enquêteur:
- Amy McQueen, Ph.D.
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria Youth:
- Children or adolescents 8-17 years of age referred for SCTCT.
- Diagnosis of malignant or nonmalignant disorder.
- Referred for any type of SCTCT. Autologous and allogeneic stem cell and cellular therapies are eligible.
- Planning to meet with a provider to discuss SCTCT.
- Must have the ability to understand and willingness to consent to participate after reviewing an IRB approved informed assent document.
- Must speak English and be cognitively able to participate.
Inclusion Criteria Parents:
- Parent or guardian of a child 8-17 years of age with any diagnosis referred for any type of SCTCT. Diagnoses may include malignant and nonmalignant disorders. Autologous and allogeneic stem cell and cellular therapies are eligible. Parent or guardian is defined as an adult who usually cares for the youth and has authority to make medical decisions for them.
- Must have the ability to understand and willingness to consent to participate after reviewing an IRB approved informed consent document.
- Must speak English and be cognitively able to participate.
Exclusion Criteria Youth:
-
Active medical problems severe enough to preclude study participation at the time of recruitment.
- Patients who are otherwise eligible, but whose primary transplant physician does not want them to participate in the study.
-
Lacks cognitive capacity to complete study activities, as determined by consenting professional.
Exclusion Criteria Parents:
- Their youth referred for SCTCT does not assent to participate.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: Non randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Let's Get REAL family health communication tool: Patients (8-12 years of age)
Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation. |
Family health communication tool |
|
Expérimental: Let's Get REAL family health communication tool: Patients (13-17 years of age)
Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation. |
Family health communication tool |
|
Expérimental: Let's Get REAL family health communication tool: Parents
Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation. |
Family health communication tool |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Feasibility of intervention as measured by the Feasibility of Intervention questionnaire
Délai: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report feasibility of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater feasibility. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Acceptability of intervention as measured by the Acceptability of Intervention questionnaire
Délai: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report acceptability of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater acceptability. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Appropriateness of intervention as measured by the Intervention of Appropriateness questionnaire
Délai: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report appropriateness of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater appropriateness. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Feasibility of intervention as measured qualitatively
Délai: Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of feasibility content codes. |
Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
|
Acceptability of intervention as measured qualitatively
Délai: Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of acceptability content codes. |
Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
|
Appropriateness of intervention as measured qualitatively
Délai: Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of appropriateness content codes. |
Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Nombre de patients ayant choisi le SCTCT
Délai: Jusqu'à 4 semaines après la consultation SCTCT (estimée à la semaine 8)
|
Jusqu'à 4 semaines après la consultation SCTCT (estimée à la semaine 8)
|
|
|
Difference in feasibility scores in those 8-12 years of age and those 13-17 years of age as measured by the Feasibility of Intervention questionnaire
Délai: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report feasibility of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater feasibility. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Difference in acceptability scores in those 8-12 years of age and those 13-17 years of age as measured by the Acceptability of Intervention questionnaire
Délai: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report acceptability of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater acceptability. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Difference in appropriateness scores in those 8-12 years of age and those 13-17 years of age as measured by the Intervention of Appropriateness questionnaire
Délai: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report appropriateness of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater appropriateness. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Perceived levels of decision-making involvement in youth 8-17 years of age and their parents as measured by the Decision Making Involvement Scale
Délai: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 30-item scale that youth and their parents report youth involvement behaviors in a decision related to their illness on a 4-point Likert scale ranging from 'A Little Bit' to 'A Lot'. The higher the subscale score (child seek, child express, parent seek, parent express, and joint/options), the more that behavior or type of involvement occurred in the decision making process. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Observed levels of decision-making involvement in youth 8-17 years of age and their parents
Délai: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
Number of utterance occurrences for the following: 1) who uttered (youth, parent), 2) was utterance prompted (yes/no), if so, by who, 3) type of utterance (questions, opinion, concern, other), and 4) content of utterance (prognosis, side effect, expectation). |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Change in youth-parent communication as measured by the Likert-type Parent-Adolescent Communication Scale
Délai: Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
|
This is a 20-item scale that youth and parents report the degree of openness in family communication and the extent of problems with family communications on a 5-point Likert ranging from 'strongly disagree' to 'strongly agree'. A higher score on the degree of openness subscale indicates better communication between parent and adolescent. For extent of problems subscale, a higher score indicates more problems in the parent-child communication. |
Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
|
|
Change in the level of youth's general anxiety as measured by the Likert-type PROMIS Anxiety 8a Short Form or parent proxy
Délai: Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
|
This is an 8-item scale that measures youth's general anxiety in those 8-17 years of age on a 5-point Likert scale ranging from 'never' to 'almost always'. |
Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
|
|
Level of decisional conflict as measured by the Likert-type Decisional Conflict Scale
Délai: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 10-item scale that youth and parents report their personal uncertainty and decisional conflict related to a specific decision. We are using the question format as it is recommended for those with limited reading or response skills. They respond 'Yes', 'No, or 'Unsure'. A total decision conflict score ranges from 0 (no decisional conflict) to 100 (extremely high decision conflict). Higher scores on subscales uncertainty, informed, values clarity, and support reflect feeling extremely uncertain about the best choice, feeling extremely uninformed, feeling extremely unclear about personal values, and feeling extremely unsupported in decision making respectively. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Youth-parent congruence of youth decision making involvement as measured by two Likert type statements
Délai: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
Number of dyads that agree on these two statements measured on a 4-point Likert scale ranging from 'Not at all' to 'A lot': 1)"I/my child should be involved in future talks about transplant" and 2) "I/my child wants to be involved in future talks about transplant". |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Satisfaction with the decision making involvement as measured by one Likert type statement
Délai: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a one item statement, "I am satisfied with my/my child's involvement in the transplant decision making process", measured on a 4-point Likert scale ranging from 'Not at all' to 'A lot'. A higher score indicates more satisfaction. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Ginny Schulz, Ph.D., RN, CPNP-PC, Washington University School of Medicine
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Troubles d'insuffisance de la moelle osseuse
- Tumeurs par site
- Tumeurs
- Maladies génétiques, innées
- Maladies du système immunitaire
- Maladies hématologiques
- Maladies de la moelle osseuse
- Anémie, hémolytique, congénitale
- Anémie, hémolytique
- Anémie
- Hémoglobinopathies
- Maladies et anomalies congénitales, héréditaires et néonatales
- Maladies nutritionnelles et métaboliques
- Maladies hémiques et lymphatiques
- Tumeurs hématologiques
- Anémie, Drépanocytose
- Syndromes d'immunodéficience
- Maladies métaboliques
- Anémie, aplasie
Autres numéros d'identification d'étude
- 202410119
- K12CA167540 (Subvention/contrat des NIH des États-Unis)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .